An open source pharma roadmap
In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.
Gespeichert in:
| Veröffentlicht in: | PLoS medicine 2017-04, Vol.14 (4), p.e1002276-e1002276 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e1002276 |
|---|---|
| container_issue | 4 |
| container_start_page | e1002276 |
| container_title | PLoS medicine |
| container_volume | 14 |
| creator | Balasegaram, Manica Kolb, Peter McKew, John Menon, Jaykumar Olliaro, Piero Sablinski, Tomasz Thomas, Zakir Todd, Matthew H Torreele, Els Wilbanks, John |
| description | In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development. |
| doi_str_mv | 10.1371/journal.pmed.1002276 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1899332014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A493733424</galeid><doaj_id>oai_doaj_org_article_4d75cbd71468428f9a1445ae88cccd98</doaj_id><sourcerecordid>A493733424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c764t-c3039f5e67031249209c1d5e810e140292d94e94c23da999badfe69465746e993</originalsourceid><addsrcrecordid>eNqVk1uL1DAUx4so7rr6DbwMCLI-dMy1aV6EYdF1YHHB22vIJKedDm3TTVrRb2-6012mMg9KHhLO-Z3_uYSTJM8xWmIq8LudG3yr62XXgF1ihAgR2YPkFHMmU5yJ7OHB-yR5EsIuMhJJ9Dg5ITnD8clOkxerduE6aBchyhlYdFvtG73wTttGd0-TR4WuAzyb7rPk-8cP3y4-pVfXl-uL1VVqRMb61FBEZcEhE4hiwiRB0mDLIccIMItZiZUMJDOEWi2l3GhbQCZZxgXLQEp6lrza63a1C2rqLCicRx8lCLNIrPeEdXqnOl812v9WTlfq1uB8qbTvK1ODYlZws7ECsyxnJC-kxoxxDXlujLEyj1rvp2zDJg7PQNt7Xc9E55622qrS_VScSo45jwLnk4B3NwOEXjVVMFDXugU3jHXnUghOyFj367_Q491NVKljA1VbuJjXjKJqxSQVlLJbrfQIVUILsUjXQlFF84xfHuHjsdBU5mjA21lAZHr41Zd6CEGtv375D_bzv7PXP-bsmwN2C7rut8HVQ1-5NsxBtgeNdyF4KO4_ECM1bsjdpNW4IWrakBj28vDz74PuVoL-AdO1BeU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899332014</pqid></control><display><type>article</type><title>An open source pharma roadmap</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Balasegaram, Manica ; Kolb, Peter ; McKew, John ; Menon, Jaykumar ; Olliaro, Piero ; Sablinski, Tomasz ; Thomas, Zakir ; Todd, Matthew H ; Torreele, Els ; Wilbanks, John</creator><creatorcontrib>Balasegaram, Manica ; Kolb, Peter ; McKew, John ; Menon, Jaykumar ; Olliaro, Piero ; Sablinski, Tomasz ; Thomas, Zakir ; Todd, Matthew H ; Torreele, Els ; Wilbanks, John</creatorcontrib><description>In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.</description><identifier>ISSN: 1549-1676</identifier><identifier>ISSN: 1549-1277</identifier><identifier>EISSN: 1549-1676</identifier><identifier>DOI: 10.1371/journal.pmed.1002276</identifier><identifier>PMID: 28419094</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject><![CDATA[Abbreviations ; African trypanosomiasis ; Alzheimer's disease ; Analysis ; Antimicrobial resistance ; Artesunate ; Business law ; Cancer ; Clinical trials ; Commercialization ; Community participation ; Competition ; Competitive Behavior ; Computer and Information Sciences ; Consumer Advocacy - standards ; Data processing ; Drug development ; Drug discovery ; Drug Discovery - economics ; Drug Discovery - methods ; Drug Discovery - organization & administration ; Drug Industry - economics ; Drug Industry - methods ; Drug Industry - organization & administration ; Health risks ; Humans ; India ; Innovations ; Life sciences ; Malaria ; Medicine and Health Sciences ; Models, Theoretical ; Neurodegenerative diseases ; Nitroimidazole ; Open source software ; Organizations, Nonprofit ; Pharmaceutical industry ; Pharmaceutical Preparations - supply & distribution ; Product development ; Public health ; R&D ; Rectum ; Research & development ; Research - economics ; Research - organization & administration ; Reviews ; Risk assessment ; Science Policy ; Social Sciences ; Software ; Specialization ; Translation ; Tropical diseases ; Tuberculosis ; Visceral leishmaniasis]]></subject><ispartof>PLoS medicine, 2017-04, Vol.14 (4), p.e1002276-e1002276</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><rights>2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Balasegaram M, Kolb P, McKew J, Menon J, Olliaro P, Sablinski T, et al. (2017) An open source pharma roadmap. PLoS Med 14(4): e1002276. https://doi.org/10.1371/journal.pmed.1002276</rights><rights>2017 Balasegaram et al 2017 Balasegaram et al</rights><rights>2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Balasegaram M, Kolb P, McKew J, Menon J, Olliaro P, Sablinski T, et al. (2017) An open source pharma roadmap. PLoS Med 14(4): e1002276. https://doi.org/10.1371/journal.pmed.1002276</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c764t-c3039f5e67031249209c1d5e810e140292d94e94c23da999badfe69465746e993</citedby><cites>FETCH-LOGICAL-c764t-c3039f5e67031249209c1d5e810e140292d94e94c23da999badfe69465746e993</cites><orcidid>0000-0001-7096-4751 ; 0000-0002-4510-0385 ; 0000-0002-7118-7744 ; 0000-0001-9296-5130</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395155/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395155/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2929,23871,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28419094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balasegaram, Manica</creatorcontrib><creatorcontrib>Kolb, Peter</creatorcontrib><creatorcontrib>McKew, John</creatorcontrib><creatorcontrib>Menon, Jaykumar</creatorcontrib><creatorcontrib>Olliaro, Piero</creatorcontrib><creatorcontrib>Sablinski, Tomasz</creatorcontrib><creatorcontrib>Thomas, Zakir</creatorcontrib><creatorcontrib>Todd, Matthew H</creatorcontrib><creatorcontrib>Torreele, Els</creatorcontrib><creatorcontrib>Wilbanks, John</creatorcontrib><title>An open source pharma roadmap</title><title>PLoS medicine</title><addtitle>PLoS Med</addtitle><description>In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.</description><subject>Abbreviations</subject><subject>African trypanosomiasis</subject><subject>Alzheimer's disease</subject><subject>Analysis</subject><subject>Antimicrobial resistance</subject><subject>Artesunate</subject><subject>Business law</subject><subject>Cancer</subject><subject>Clinical trials</subject><subject>Commercialization</subject><subject>Community participation</subject><subject>Competition</subject><subject>Competitive Behavior</subject><subject>Computer and Information Sciences</subject><subject>Consumer Advocacy - standards</subject><subject>Data processing</subject><subject>Drug development</subject><subject>Drug discovery</subject><subject>Drug Discovery - economics</subject><subject>Drug Discovery - methods</subject><subject>Drug Discovery - organization & administration</subject><subject>Drug Industry - economics</subject><subject>Drug Industry - methods</subject><subject>Drug Industry - organization & administration</subject><subject>Health risks</subject><subject>Humans</subject><subject>India</subject><subject>Innovations</subject><subject>Life sciences</subject><subject>Malaria</subject><subject>Medicine and Health Sciences</subject><subject>Models, Theoretical</subject><subject>Neurodegenerative diseases</subject><subject>Nitroimidazole</subject><subject>Open source software</subject><subject>Organizations, Nonprofit</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceutical Preparations - supply & distribution</subject><subject>Product development</subject><subject>Public health</subject><subject>R&D</subject><subject>Rectum</subject><subject>Research & development</subject><subject>Research - economics</subject><subject>Research - organization & administration</subject><subject>Reviews</subject><subject>Risk assessment</subject><subject>Science Policy</subject><subject>Social Sciences</subject><subject>Software</subject><subject>Specialization</subject><subject>Translation</subject><subject>Tropical diseases</subject><subject>Tuberculosis</subject><subject>Visceral leishmaniasis</subject><issn>1549-1676</issn><issn>1549-1277</issn><issn>1549-1676</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNqVk1uL1DAUx4so7rr6DbwMCLI-dMy1aV6EYdF1YHHB22vIJKedDm3TTVrRb2-6012mMg9KHhLO-Z3_uYSTJM8xWmIq8LudG3yr62XXgF1ihAgR2YPkFHMmU5yJ7OHB-yR5EsIuMhJJ9Dg5ITnD8clOkxerduE6aBchyhlYdFvtG73wTttGd0-TR4WuAzyb7rPk-8cP3y4-pVfXl-uL1VVqRMb61FBEZcEhE4hiwiRB0mDLIccIMItZiZUMJDOEWi2l3GhbQCZZxgXLQEp6lrza63a1C2rqLCicRx8lCLNIrPeEdXqnOl812v9WTlfq1uB8qbTvK1ODYlZws7ECsyxnJC-kxoxxDXlujLEyj1rvp2zDJg7PQNt7Xc9E55622qrS_VScSo45jwLnk4B3NwOEXjVVMFDXugU3jHXnUghOyFj367_Q491NVKljA1VbuJjXjKJqxSQVlLJbrfQIVUILsUjXQlFF84xfHuHjsdBU5mjA21lAZHr41Zd6CEGtv375D_bzv7PXP-bsmwN2C7rut8HVQ1-5NsxBtgeNdyF4KO4_ECM1bsjdpNW4IWrakBj28vDz74PuVoL-AdO1BeU</recordid><startdate>20170418</startdate><enddate>20170418</enddate><creator>Balasegaram, Manica</creator><creator>Kolb, Peter</creator><creator>McKew, John</creator><creator>Menon, Jaykumar</creator><creator>Olliaro, Piero</creator><creator>Sablinski, Tomasz</creator><creator>Thomas, Zakir</creator><creator>Todd, Matthew H</creator><creator>Torreele, Els</creator><creator>Wilbanks, John</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><scope>CZK</scope><orcidid>https://orcid.org/0000-0001-7096-4751</orcidid><orcidid>https://orcid.org/0000-0002-4510-0385</orcidid><orcidid>https://orcid.org/0000-0002-7118-7744</orcidid><orcidid>https://orcid.org/0000-0001-9296-5130</orcidid></search><sort><creationdate>20170418</creationdate><title>An open source pharma roadmap</title><author>Balasegaram, Manica ; Kolb, Peter ; McKew, John ; Menon, Jaykumar ; Olliaro, Piero ; Sablinski, Tomasz ; Thomas, Zakir ; Todd, Matthew H ; Torreele, Els ; Wilbanks, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c764t-c3039f5e67031249209c1d5e810e140292d94e94c23da999badfe69465746e993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abbreviations</topic><topic>African trypanosomiasis</topic><topic>Alzheimer's disease</topic><topic>Analysis</topic><topic>Antimicrobial resistance</topic><topic>Artesunate</topic><topic>Business law</topic><topic>Cancer</topic><topic>Clinical trials</topic><topic>Commercialization</topic><topic>Community participation</topic><topic>Competition</topic><topic>Competitive Behavior</topic><topic>Computer and Information Sciences</topic><topic>Consumer Advocacy - standards</topic><topic>Data processing</topic><topic>Drug development</topic><topic>Drug discovery</topic><topic>Drug Discovery - economics</topic><topic>Drug Discovery - methods</topic><topic>Drug Discovery - organization & administration</topic><topic>Drug Industry - economics</topic><topic>Drug Industry - methods</topic><topic>Drug Industry - organization & administration</topic><topic>Health risks</topic><topic>Humans</topic><topic>India</topic><topic>Innovations</topic><topic>Life sciences</topic><topic>Malaria</topic><topic>Medicine and Health Sciences</topic><topic>Models, Theoretical</topic><topic>Neurodegenerative diseases</topic><topic>Nitroimidazole</topic><topic>Open source software</topic><topic>Organizations, Nonprofit</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceutical Preparations - supply & distribution</topic><topic>Product development</topic><topic>Public health</topic><topic>R&D</topic><topic>Rectum</topic><topic>Research & development</topic><topic>Research - economics</topic><topic>Research - organization & administration</topic><topic>Reviews</topic><topic>Risk assessment</topic><topic>Science Policy</topic><topic>Social Sciences</topic><topic>Software</topic><topic>Specialization</topic><topic>Translation</topic><topic>Tropical diseases</topic><topic>Tuberculosis</topic><topic>Visceral leishmaniasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balasegaram, Manica</creatorcontrib><creatorcontrib>Kolb, Peter</creatorcontrib><creatorcontrib>McKew, John</creatorcontrib><creatorcontrib>Menon, Jaykumar</creatorcontrib><creatorcontrib>Olliaro, Piero</creatorcontrib><creatorcontrib>Sablinski, Tomasz</creatorcontrib><creatorcontrib>Thomas, Zakir</creatorcontrib><creatorcontrib>Todd, Matthew H</creatorcontrib><creatorcontrib>Torreele, Els</creatorcontrib><creatorcontrib>Wilbanks, John</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><collection>PLoS Medicine</collection><jtitle>PLoS medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balasegaram, Manica</au><au>Kolb, Peter</au><au>McKew, John</au><au>Menon, Jaykumar</au><au>Olliaro, Piero</au><au>Sablinski, Tomasz</au><au>Thomas, Zakir</au><au>Todd, Matthew H</au><au>Torreele, Els</au><au>Wilbanks, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An open source pharma roadmap</atitle><jtitle>PLoS medicine</jtitle><addtitle>PLoS Med</addtitle><date>2017-04-18</date><risdate>2017</risdate><volume>14</volume><issue>4</issue><spage>e1002276</spage><epage>e1002276</epage><pages>e1002276-e1002276</pages><issn>1549-1676</issn><issn>1549-1277</issn><eissn>1549-1676</eissn><abstract>In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>28419094</pmid><doi>10.1371/journal.pmed.1002276</doi><orcidid>https://orcid.org/0000-0001-7096-4751</orcidid><orcidid>https://orcid.org/0000-0002-4510-0385</orcidid><orcidid>https://orcid.org/0000-0002-7118-7744</orcidid><orcidid>https://orcid.org/0000-0001-9296-5130</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1549-1676 |
| ispartof | PLoS medicine, 2017-04, Vol.14 (4), p.e1002276-e1002276 |
| issn | 1549-1676 1549-1277 1549-1676 |
| language | eng |
| recordid | cdi_plos_journals_1899332014 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Abbreviations African trypanosomiasis Alzheimer's disease Analysis Antimicrobial resistance Artesunate Business law Cancer Clinical trials Commercialization Community participation Competition Competitive Behavior Computer and Information Sciences Consumer Advocacy - standards Data processing Drug development Drug discovery Drug Discovery - economics Drug Discovery - methods Drug Discovery - organization & administration Drug Industry - economics Drug Industry - methods Drug Industry - organization & administration Health risks Humans India Innovations Life sciences Malaria Medicine and Health Sciences Models, Theoretical Neurodegenerative diseases Nitroimidazole Open source software Organizations, Nonprofit Pharmaceutical industry Pharmaceutical Preparations - supply & distribution Product development Public health R&D Rectum Research & development Research - economics Research - organization & administration Reviews Risk assessment Science Policy Social Sciences Software Specialization Translation Tropical diseases Tuberculosis Visceral leishmaniasis |
| title | An open source pharma roadmap |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A13%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20open%20source%20pharma%20roadmap&rft.jtitle=PLoS%20medicine&rft.au=Balasegaram,%20Manica&rft.date=2017-04-18&rft.volume=14&rft.issue=4&rft.spage=e1002276&rft.epage=e1002276&rft.pages=e1002276-e1002276&rft.issn=1549-1676&rft.eissn=1549-1676&rft_id=info:doi/10.1371/journal.pmed.1002276&rft_dat=%3Cgale_plos_%3EA493733424%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899332014&rft_id=info:pmid/28419094&rft_galeid=A493733424&rft_doaj_id=oai_doaj_org_article_4d75cbd71468428f9a1445ae88cccd98&rfr_iscdi=true |